Astrazeneca

FASLODEX

  1. Home
  2.  / 
  3. J Code
  4.  / FASLODEX – J9395

Manufacturer:

Astrazeneca

Name:

FASLODEX

HCPCS Code Descriptor:

Injection, fulvestrant, 25 mg

Category:

J Code

HCPCS:

J9395

NDC(s):

72603-0105-02, 71288-0555-86, 70860-0211-74, 70710-1688-08, 70700-0284-98, 70121-1463-02, 68462-0317-32, 68001-0522-85, 68001-0484-85, 67457-0311-05, 43598-0262-02, 25021-0462-74, 16729-0436-30, 16714-0070-02, 00781-3492-12, 00781-3079-12, 00310-0720-10, 00143-9022-02

Primary Type:

Oncology

Generic Status:

Multi-Source

Route of Administration:

Intramuscular

About:

FASLODEX is an Oncology drug manufactured by Astrazeneca and administered via the Intramuscular route of administration. The J Code: J9395 is aligned to the drug FASLODEX.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/04

HCPCS Effective Date:

1/1/04

HCPCS Short Description:

Injection, fulvestrant

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.azandmeapp.com/prescriptionsavings/

https://www.myaccess36.com/home.html

FASLODEX - J9395